Role of 5 Alpha-Reductase Inhibitors in the Management of Prostate Cancer

    December 2006 in “ Clinical interventions in aging ”
    Steven J. Hudak, Javier Hernández, Ian M. Thompson
    TLDR 5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.
    The document reviewed the role of 5 alpha-reductase inhibitors, such as finasteride and dutasteride, in managing prostate cancer. These inhibitors were shown to reduce PSA levels and prostate volume, potentially delaying cancer progression. Clinical trials, including the Prostate Cancer Prevention Trial with 18,882 men, indicated a nearly 25% reduction in prostate cancer risk with finasteride, though concerns about high-grade cancer diagnoses were noted. Dutasteride also showed promise, with ongoing trials like REDUCE evaluating its efficacy. While these inhibitors were well-tolerated and showed some efficacy, definitive evidence of improved survival was lacking, necessitating further research to confirm their benefits and address safety concerns.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      November 2020 in “Elsevier eBooks”
      Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.
      5-Alpha-Reductase Inhibitors and Combination Therapy

      research 5-Alpha-Reductase Inhibitors and Combination Therapy

      15 citations, July 2016 in “Urologic Clinics of North America”
      Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.
      5α-Reductase Inhibitors

      research 5α-Reductase Inhibitors

      17 citations, November 1997 in “Andrology”
      Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.